GT APEIRON THERAPEUTICS
GT Apeiron Therapeutics is a developer of innovative drugs utilizing artificial intelligence technology. The company develops breakthrough investigational medicines by harnessing the power of artificial intelligence, aiming to drastically increase efficiency throughout the drug discovery process.
GT APEIRON THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2019-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.gthcap.com
Total Employee:
11+
Status:
Active
Total Funding:
27 M USD
Similar Organizations
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
JW Therapeutics
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Rain Therapeutics
Rain Therapeutics is a operator of a clinical stage biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
GT Healthcare Capital Partners
GT Healthcare Capital Partners investment in Venture Round - GT Apeiron Therapeutics
More informations about "GT Apeiron Therapeutics"
GT CAPITAL - gthcap.com
GT Healthcare Capital Partners (“GT Healthcare”) is an Asia-based private investment partnership that specializes in healthcare investments around the globe that aim to change technology landscapes.See details»
GT CAPITAL
【GT创投新闻】Potrero Medical因Accuryn-AKI预测算法获得FDA突破性医疗设备认定. 2022年09月14日; 作者编辑： GT创投被投企业Potrero Medical在2022年9月13日宣布，FDA批准了 …See details»
GT CAPITAL - gthcap.com
Boundless Bio Announces $100 Million Oversubscribed Series C Financing co-led by. 2023年05月18日; Author edit: mf123456 Boundless Bio announced the closing of a $100 million …See details»
Gt Capital Company Profile | Management and Employees List
[email protected]: 4: first: [email protected]: 5: last: [email protected]: Your Questions, Our Answers Get Free Access to Gt Capital Contacts Info. What is Gt Capital …See details»
GT Healthcare Capital Partners - Crunchbase
Contact Email [email protected] GT Healthcare Capital Partners (“GT Healthcare”) is an Asia-based private investment partnership that specializes in healthcare investments around the globe that aim to change technology …See details»
GT Healthcare Capital Partners | Institution Profile | Private Equity ...
Website: www.gthcap.com. Email: [email protected]. You are viewing a preview of the articles and data available. Get access. GT Healthcare Capital Partners contact information. Offices …See details»
Gt Capital - Overview, News & Similar companies | ZoomInfo.com
View Gt Capital (www.gthcap.com) location in China , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
GT Healthcare Capital Partners - LinkedIn
GT Healthcare Capital Partners | 799 followers on LinkedIn. GT Healthcare Capital Partners is a healthcare investment firm backing global leaders and bridging innovative technologies across ...See details»
Founder Lodge | Exchange with founders who raised capital, hired ...
GT Healthcare Capital Partners is a healthcare investment firm backing global leaders and bridging innovative technologies across continents to transform patient care.See details»
GT CAPITAL - gthcap.com
Jun 8, 2022 Professor Yuk Lam Lo has extensive experience in biotechnology industry, corporate management, academic research and community service. Currently Professor Lo is …See details»
GT Healthcare Capital Partners (GT Healthcare Capital Partners)
SAN DIEGO--( BUSINESS WIRE )--Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic …See details»
GT Healthcare Capital Partners investment portfolio - PitchBook
Www.gthcap.com. Investor Status. Actively Seeking New Investments. Primary Investor Type. Venture Capital. Corporate Office. Room 403, 4/F Nan Fung Tower; 88 Connaught Road …See details»
GT Healthcare Capital Partners | 领英 - 领英 (中国)
We are excited to announce that EchoGo® Amyloidosis has received Breakthrough Device FDA clearance! Developed in collaboration with Johnson & Johnson Innovative Medicine and with …See details»
GT CAPITAL - gthcap.com
OSI has raised £580 million ($706 million), with first-round investors including Google Ventures and the Wellcome Trust and the second round led by Asian investors. Since its foundation in …See details»
GT Healthcare Capital Partners - Golden
GT Healthcare Capital Partners is a venture capital firm headquartered in Hong Kong.It was founded in September 2015 by former pharmaceutical executive Alan Au. It makes early stage …See details»
GT Healthcare-动脉网 - vbdata.cn
Sep 1, 2015 GT Healthcare Capital Partners专注于全球医疗保健投资，并为大中华区的医疗保健业务提供资金和规模专业知识。See details»
GT创投 - m.itjuzi.com
GT创投(GT Healthcare Capital Partners)成立于2018年，是一家亚洲私募股权投资机构，专门从事全球革命性创新医疗技术的投资。GT创投旨在为大中华地区及亚洲的医疗健康事业发展提供 …See details»
团队_GT创投 - gthcap.com
Gt创投长期关注全球领先的、具有革命性的创新药和医疗技术，以科技进步和市场应用有机结合为投资驱动力，致力于变革亚洲乃至全球的医疗技术格局，致力于从投资者角度切入，为全球患 …See details»
GT创投的简介、联系方式 | IT桔子 - itjuzi.com
GT创投(GT Healthcare Capital Partners)成立于2018年，是一家亚洲私募股权投资机构，专门从事全球革命性创新医疗技术的投资。GT创投旨在为大中华地区及亚洲的医疗健康事业发展提供 …See details»
GT CAPITAL - gthcap.com
Marcus Hui joined GT Healthcare Capital Partners in 2021 and comes with 10 years of experience in life sciences and healthcare. Prior to joining GT, Marcus served at HKSTP, the leading …See details»